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Melanotic schwannoma (MS) is a rare variant of nerve sheath neoplasm that shows ultrastructural 
and immunophenotypical features of Schwann cells but also has cytoplasmic melanosomes and 
is reactive for melanocytic markers as well. Unlike conventional schwannoma, which is totally 
benign, MS has an unpredictable prognosis and is thought to have low-malignant potential. 
Herein, we present a rare case of recurrent MS in lumbar spine of a 59-year-old male. 
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▒ CASE STUDY ▒
Melanotic schwannoma (MS) is a rare, distinctive tumor which 
is categorized as a variant of schwannoma. Approximately 50% 
of MS have psammomatous calcifications, which is related to 
Carney complex, an autosomal dominant disorder.1 Tumor cells 
of MS are thought to be Schwann cells that characteristically 
have melanosomes and are immunophenotypically reactive for 
melanocytic markers.2 We report a case of MS that had occurred in 
lumbar spinal nerve of a 59-year-old male, which locally recurred 
5 years after the surgical removal of the primary tumor and also 
metastasized to the lung. 
CASE REPORT
This study was approved by the Institutional Review Board 
of Gangnam Severance Hospital with a waiver of informed con-
sent (IRB No. 3-2016-0255).
A 59-year-old male presented with right buttock pain and 
radiating leg pain. He had a medical history of hypertension on 
medication for 10 years. Five years ago, he had a hemi-laminec-
tomy with removal of a spinal cord mass of left L4 level, at the 
outside hospital, and the diagnosis was MS. On spinal magnetic 
resonance imaging, tumor in previous operative site, L4 level of 
spinal cord, was recognized with involvement of L4 vertebral 
body (Fig. 1A). Tumor recurrence was considered based on the 
patient’s history. Subsequent positron emission tomography–
computed tomography revealed strong fluorodeoxyglucose 
(FDG) uptake in the L4/5 level. Multiple lung nodules with 
increased FDG uptake were found in the left upper lobe, right 
middle lobe, and right lower lobe, which appeared to be consis-
tent with metastatic nodules (Fig. 1B). Patient received total 
laminectomy of L4 and subtotal laminectomy of L3 lower and 
L5 upper bodies. The resected specimen submitted in fresh 
http://jpatholtm.org/ https://doi.org/10.4132/jptm.2017.01.04
506     •  Choi S-E, et al.
state consisted of a product of L4 corpectomy, including a body 
of L4 spinal bone and separately sent soft tissue. A 3.3 × 2.2-cm-
sized black, soft mass was located in the posterior side of the L4 
body. On cut section, the black mass was infiltrating into the 
bone (Fig. 2A). 
On histological examination, a cellular pigmented mass was 
infiltrating the bone marrow (Fig. 2B). Discohesive tumor cells 
were arranged in solid sheets or nests. Tumor cells had eosino-
philic ample cytoplasm, long cytoplasmic process with fuzzy cell 
borders, and variable amounts of cytoplasmic melanin pigments. 
Nuclear pleomorphism and prominent macronucleoli were 
observed with a few mitoses up to 2/10 high power fields (HPFs) 
(Fig. 2C). Foci of tumor necrosis were observed (Fig. 2D). Im-
munohistochemical staining for human melanoma black 45 
(HMB45; 1:100, clone HMB45, Dako, Carpinteria, CA, USA), 
S-100 protein (1:2,000, clone bBS/NC/VI-H14, Dako), Ki-67 
Fig. 1. Radiologic findings of spinal melanotic schwannoma. (A) Magnetic resonance imaging of lumbar spine reveals a destructive mass of 
the vertebral body. (B) Metastatic pulmonary nodule in left upper lobe with increased fluorodeoxyglucose uptake on positron emission to-
mography–computed tomography (arrowheads).
BA
Fig. 2. Gross, microscopic and ultrastructural findings of melanotic schwannoma. (A) A heavily pigmented black round mass of vertebral 
body has infiltrative margin. (B) Tumor cells permeate the bone marrow space of vertebra (left). Note the right sided normal bone marrow 
that shows retained trabecular bone and marrow space containing hematopoietic cells. (C) Epithelioid tumor cells have discernible cytoplas-
mic membrane, pleomorphic nuclei, and cytoplasmic melanin pigments. Note the mitosis (center) and prominent nucleolus. (D) Foci of tumor 
necrosis are seen. Human melanoma black 45 (E) and S-100 protein (F) are diffusely and strongly positive in tumor cells. (G) Collagen type IV 
staining reveals pericellular membranous staining of tumor cells, implying the presence of basal lamina. (H) On electron microscopy, abun-
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(1:150, clone MIB-1, Dako), and collagen type IV (1:100, clone 
CIV 22, Dako) was performed. Tumor cells showed diffuse and 
strong expression of HMB45 and S-100 protein (Fig. 2E, F). Col-
lagen type IV was expressed along the pericellular membrane 
(Fig. 2G). Ki-67 was positive in approximately 1% of the tumor 
cells. Under electron microscopy, abundant basal lamina (Fig. 2H) 
was observed along with the cytoplasmic melanosomes (Fig. 2H, 
inset). 
DISCUSSION
We reported a rare case of spinal MS that showed local recur-
rence and pulmonary metastasis. MS is a rare variant of nerve 
sheath neoplasm of which less than 200 cases have been reported 
to date with three cases in Korean reports.2-5 MS can be divided 
into psammomatous and nonpsammomatous type,2 and approx-
imately half of the psammomatous MS are related to Carney 
complex, an autosomal dominant disease with cardiac myxomas 
and Cushing syndrome.6 Nonpsammomatous MS is considered 
to be a sporadic type and commonly affects spinal nerves and 
paraspinal ganglia, whereas psammomatous type often involves 
autonomic nerves of viscera. In contrast to the typical encapsula-
tion of conventional schwannoma, MS is a circumscribed but 
unencapsulated tumor, which may reflect the potential of more 
aggressive nature of MS such as an invasive growth pattern. In 
present study, the tumor showed infiltrative border that perme-
ated the bone marrow space. Unlike the conventional schwan-
noma, which is a totally benign neoplasm, MS follows an unpre-
dictable clinical course. Even devoid of overt histologic atypia, 
approximately 10% of MS follow a malignant course.2,7 Although 
MS could demonstrate nuclear pleomorphism and macronucleoli 
with expression of melanocytic markers, findings mimicking 
malignant melanoma, these histologic features are poorly corre-
lated with the clinical outcome. However, unlike malignant mel-
anoma which usually has frequent mitosis, MS has rare mitosis. 
In addition, histologic features of ample cytoplasm, cytoplasmic 
process, and indiscernable cell border as well as low proliferative 
index contribute to the diagnosis of MS rather than malignant 
melanoma. Presence of mitosis itself, particularly over one mitosis/ 
10HPFs, is the only known risk factor of metastasis in MS.8 In 
present case, the tumor had histologic atypia—nuclear pleomor-
phism, prominent macronucleoli—and foci of necrosis which are 
worrisome histologic features in routine pathologic diagnosis. More-
over, more importantly, the mitotic count was up to 2 /10HPFs, 
which may have been a factor attributing to the lung metastasis. 
Recently, Torres-Mora et al.8 carried out gene microarray study 
covering over 1,700 genes, showed different gene expression 
profile of MS from conventional schwannoma or malignant mela-
noma, and suggested that MS is a distinctive neoplasm, belong-
ing neither to the conventional schwannoma nor malignant mel-
Table 1. Previously reported melanotic schwannomas with metastasis 
Case No. Sex Age (yr) Primary site Metastasis site References
1 M 27 Bronchus Brain Rowlands et al.15 (1987) 
2 F 48 T9–T10 Lung, skin Killeen et al.16 (1988)
3 M 27 L5 Lung, pleura Vallat-Decouvelaere et al.7 (1999)
4 F 35 L3–L5 Bone, lymph node Vallat-Decouvelaere et al.7 (1999) 
5 F 45 T6 Lung, bone, liver Vallat-Decouvelaere et al.7 (1999) 
6 M 35 C4–C5 Leptomeninges Santaguida et al.10 (2004) 
7 M 61 T7 Leptomeninges Tawk et al.11 (2005) 
8 M 33 L5–S1 Lung Shields et al.12 (2011) 
9 F 32 C4–C5 Lung Faria et al.13 (2013) 
10 F 15 Cervical paraspinal Leptomeninges, parascapular, and neck soft tissues Torres-Mora et al.8 (2014) 
11 F 23 L4 Liver Torres-Mora et al.8 (2014) 
12 F 25 Sacrum Lung, pleura, lymph nodes Torres-Mora et al.8 (2014) 
13 M 27 L2–L3 Lung, lymph nodes, abdomen Torres-Mora et al.8 (2014) 
14 M 32 C2 nerve root Lung, skeleton Torres-Mora et al.8 (2014) 
15 M 40 Paraspinal L3–L4 Spine (T12) Torres-Mora et al.8 (2014) 
16 F 44 T5–6 Lung, posterior chest wall Torres-Mora et al.8 (2014) 
17 M 47 L3–L4 Lung, liver, pleura, leptomeninges, bone Torres-Mora et al.8 (2014) 
18 M 47 C5 Lumbar/thoracic, brain Torres-Mora et al.8 (2014) 
19 M 61 T6–T8 Spinal cord Torres-Mora et al.8 (2014) 
20 F 67 T10 Liver Torres-Mora et al.8 (2014) 
21 M 46 L3 Brain, leptomeninges Khoo et al.14 (2016) 
M, male; F, female; T, thoracic spine; L lumbar spine; C, cervical spine.
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anoma. Among pigmented lesions of central nervous system, MS 
lacks GNAQ codon 209 mutations, which is one of mutational 
descriptors found in leptomeningeal melanocytic lesions.9 Al-
though MS is a genetically interesting and ambiguous tumor, a 
genetic study of the present case was not available. Instead, im-
munohistochemical staining and electron microscopy helped to 
identify the abundant basal lamina and cytoplasmic melano-
somes, which elucidated the features of both Schwann cell and 
melanocyte. Previous study described different basement mem-
brane staining patterns of MS from conventional schwannoma 
and leptomeningeal melanocytic lesion.9 MS demonstrated peri-
cellular staining of basement membrane on collagen type IV, 
similar to that of conventional schwannoma with or without a 
nesting pattern, whereas other melanocytic lesions had predomi-
nant nesting pattern.9
So far, only about 20 cases of metastatic MS have been report-
ed,7,8,10-16 which are shown in Table 1. This is the first metastatic 
and recurrent MS case in a Korean patient. The sporadic, spinal 
MS showed an aggressive biologic behavior—local recurrence 
and pulmonary metastasis—and the ancillary examination delin-
eated the pericellular basal lamina and cytoplasmic melanosomes. 
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